Maternal and fetal outcome among pregnant women with jaundice and deranged LFTs attending a tertiary care institute: a prospective study
Keywords:Jaundice, Deranged LFTs, Pregnancy, Fetal outcome, Maternal outcome, ICP
Background: This was a prospective study to analyses the maternal and fetal outcome among pregnant women with jaundice and deranged LFTs in a tertiary care hospital.
Methods: This was a prospective observational study conducted in the department of Obstetrics and Gynaecology at SLBSGMC Nerchowk for a period of 6 months. The pregnant women with jaundice and deranged LFTs were included in the study after fulfilling inclusion and exclusion criteria. History, clinical examination and relevant investigations done. All patients followed till seven days in post-partum period. The maternal and fetal outcomes were noted.
Results: During study period we encountered 59 pregnant women with deranged LFTs. Majority of women were in primigravida (74.6%) in 20-30 years (55.9%) of age group. Most common symptom was pruritus in 59.3% of women. ICP was the most common cause amongst 64.4% of women. 40.7% 0f women had FTVD and 40.6% had cesarean delivery. AFD with MSL (87.5%) being the most common indication for cesarean delivery amongst these women. A total of 49 (83.1%) of newborn were delivered alive with good Apgar score, 1 (1.7%) was premature, 1 (1.7%) had respiratory distress syndrome (RDS).
Conclusions: In contrary to older Indian studies our study concluded that though liver disease is less common, but on evaluation we found that intra-hepatic cholestasis being the number one cause of deranged LFTs in pregnancy in our hospital. Amongst these patients with high index of suspicion, prompt investigations, early diagnosis and timely management can improve the maternal and perinatal outcome.
Walker I, Chappell LC, Williamson C. Abnormal liver function tests in pregnancy. BMJ. 2013;347:f6055.
Cunningham FG, Leveno KJ, Bloom SL, Hauth C, Gilstrap LC, Wenstrom KD. Hepatic, biliary tract and pancreatic disorders. In: William’s Obstetrics. 22nd ed. New York: McGraw Hill Professional; 2005: 1125-1126.
García AL. Effect of pregnancy on pre-existing liver disease physiological changes during pregnancy. Ann Hepatol. 2006;5(3):184-6.
Patra KK, Chattopadhyay S, Biswas S, Hadi A. Asian J Med Sci. 2022;13(8):80-6.
Singh KN, Jain A, Khare R, Asati P. Study of liver disorders during pregnancy and feto-maternal outcome in a tertiary care hospital. Int J Health Clin Res. 2021;4(7):54-7.
Dang A, Agarwal N, Bathla S, Sharma N, Balani S. Prevalence of liver disease in pregnancy and its outcome with emphasis on obstetric cholestasis: an Indian scenario. J Obstet Gynecol India. 2010;60(6):413-8.
Sultana R, Sarwar I, Fawad A, Noor S, Bashir R. Neonatal outcome in obstetric cholestasis patients at Ayub Teaching Hospital Abbottabad. J Ayub Med Coll Abbottabad. 2009;21(4):76-8.
Tripathi R, Brahmane M, Jain SB. Effect of abnormal liver function test on maternal and perinatal outcome in pregnancy: observational study. Int J Reprod Contracept Obstet Gynecol. 2020;9:4063-7.
Mishra N, Mishra VN, Thakur P. Study of Abnormal Liver Function Test during Pregnancy in a Tertiary Care Hospital in Chhattisgarh. J Obstet Gynaecol India. 2016;66(1):129-35.
Patra KA, Chattopadhyay S, Biswas S, Hadi AMD. A study of abnormal liver function in pregnancy and its correlation with feto-maternal outcome in a teaching hospital of Kolkata in Eastern India. Asian J Med Sci.2022;13(8):80-6.
Mbachu II, Udigwe GO, Okafor CI, Umeonunihu OS, Ezeama C, Eleje GU. The pattern and obstetric outcome of hypertensive disorders of pregnancy in Nnewi, Nigeria. Niger J Med. 2013;22(2):117-22.
Kirbak ALS, Ng'ang'a Z, Omolo J, Idris H, Usman A, Mbabazi WB. Sero-prevalence for Hepatitis B virus among pregnant women attending antenatal clinic in Juba Teaching Hospital, Republic of South Sudan. Pan Afr Med J. 2017;26:72.